Arkolith/Insider Trading/RAPP/Form 4

Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Sep 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$206K
Net Open-Market Flow
-$206K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2025Sell(S)5K$23.88$122K422K
Sep 15, 2025Sell(S)3K$24.66$84K418K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-206203) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML